19.6 USD
+1.55 (+8.59%)
20 USD
+0.4 (+2.04%)
SLP gets a fundamental rating of 6 out of 10. The analysis compared the fundamentals against 35 industry peers in the Health Care Technology industry. SLP is in great health and has no worries on liquidiy or solvency at all, but the profibility rating is only average. SLP is not priced too expensively while it is growing strongly. Keep and eye on this one!
1. Profitability
1.1 Basic Checks
SLP had positive earnings in the past year.
In the past year SLP had a positive cash flow from operations.
Of the past 5 years SLP 4 years were profitable.
SLP had a positive operating cash flow in each of the past 5 years.
1.2 Ratios
Looking at the Return On Assets, with a value of -49.05%, SLP is doing worse than 71.43% of the companies in the same industry.
SLP has a Return On Equity (-51.86%) which is in line with its industry peers.
With a decent Return On Invested Capital value of 4.16%, SLP is doing good in the industry, outperforming 71.43% of the companies in the same industry.
Measured over the past 3 years, the Average Return On Invested Capital for SLP is below the industry average of 6.61%.
The 3 year average ROIC (3.61%) for SLP is below the current ROIC(4.16%), indicating increased profibility in the last year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -49.05% | ||
| ROE | -51.86% | ||
| ROIC | 4.16% |
ROA(3y)-12.88%
ROA(5y)-5.32%
ROE(3y)-13.51%
ROE(5y)-5.53%
ROIC(3y)3.61%
ROIC(5y)4.56%
1.3 Margins
SLP has a better Operating Margin (8.20%) than 82.86% of its industry peers.
SLP's Operating Margin has declined in the last couple of years.
SLP has a Gross Margin (58.38%) which is comparable to the rest of the industry.
SLP's Gross Margin has declined in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 8.2% | ||
| PM (TTM) | N/A | ||
| GM | 58.38% |
OM growth 3Y-33.32%
OM growth 5Y-21.72%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-9.94%
GM growth 5Y-4.73%
2. Health
2.1 Basic Checks
The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so SLP is destroying value.
Compared to 1 year ago, SLP has more shares outstanding
SLP has more shares outstanding than it did 5 years ago.
SLP has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
2.2 Solvency
An Altman-Z score of 34.00 indicates that SLP is not in any danger for bankruptcy at the moment.
With an excellent Altman-Z score value of 34.00, SLP belongs to the best of the industry, outperforming 100.00% of the companies in the same industry.
SLP has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | 0 | ||
| Altman-Z | 34 |
ROIC/WACC0.43
WACC9.68%
2.3 Liquidity
A Current Ratio of 7.67 indicates that SLP has no problem at all paying its short term obligations.
The Current ratio of SLP (7.67) is better than 88.57% of its industry peers.
SLP has a Quick Ratio of 7.67. This indicates that SLP is financially healthy and has no problem in meeting its short term obligations.
Looking at the Quick ratio, with a value of 7.67, SLP belongs to the top of the industry, outperforming 88.57% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 7.67 | ||
| Quick Ratio | 7.67 |
3. Growth
3.1 Past
SLP shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 75.00%, which is quite impressive.
SLP shows a small growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 1.07% yearly.
SLP shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 13.09%.
Measured over the past years, SLP shows a quite strong growth in Revenue. The Revenue has been growing by 13.74% on average per year.
EPS 1Y (TTM)75%
EPS 3Y-1.12%
EPS 5Y1.07%
EPS Q2Q%1200%
Revenue 1Y (TTM)13.09%
Revenue growth 3Y13.67%
Revenue growth 5Y13.74%
Sales Q2Q%-2.66%
3.2 Future
Based on estimates for the next years, SLP will show a very strong growth in Earnings Per Share. The EPS will grow by 22.12% on average per year.
The Revenue is expected to grow by 10.39% on average over the next years. This is quite good.
EPS Next Y32.34%
EPS Next 2Y29.52%
EPS Next 3Y2.03%
EPS Next 5Y22.12%
Revenue Next Year1.9%
Revenue Next 2Y4.44%
Revenue Next 3Y5.79%
Revenue Next 5Y10.39%
3.3 Evolution
The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
4. Valuation
4.1 Price/Earnings Ratio
The Price/Earnings ratio is 28.00, which means the current valuation is very expensive for SLP.
Based on the Price/Earnings ratio, SLP is valued a bit cheaper than the industry average as 77.14% of the companies are valued more expensively.
When comparing the Price/Earnings ratio of SLP to the average of the S&P500 Index (27.19), we can say SLP is valued inline with the index average.
A Price/Forward Earnings ratio of 20.14 indicates a rather expensive valuation of SLP.
Based on the Price/Forward Earnings ratio, SLP is valued a bit cheaper than the industry average as 80.00% of the companies are valued more expensively.
SLP is valuated at similar levels of the S&P average when we compare the Price/Forward Earnings ratio to 23.92, which is the current average of the S&P500 Index.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 28 | ||
| Fwd PE | 20.14 |
4.2 Price Multiples
Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of SLP indicates a somewhat cheap valuation: SLP is cheaper than 65.71% of the companies listed in the same industry.
Based on the Price/Free Cash Flow ratio, SLP is valued a bit cheaper than 71.43% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 27.41 | ||
| EV/EBITDA | 24.55 |
4.3 Compensation for Growth
The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
PEG (NY)0.87
PEG (5Y)26.22
EPS Next 2Y29.52%
EPS Next 3Y2.03%
5. Dividend
5.1 Amount
SLP has a yearly dividend return of 0.61%, which is pretty low.
Compared to an average industry Dividend Yield of 0.54, SLP pays a better dividend. On top of this SLP pays more dividend than 94.29% of the companies listed in the same industry.
With a Dividend Yield of 0.61, SLP pays less dividend than the S&P500 average, which is at 1.92.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0.61% |
5.2 History
SLP has been paying a dividend for at least 10 years, so it has a reliable track record.
Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0
5.3 Sustainability
DP0%
EPS Next 2Y29.52%
EPS Next 3Y2.03%
19.6
+1.55 (+8.59%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Technology
Earnings (Last)
Earnings (Next)
Inst Owners79.38%
Inst Owner Change0.01%
Ins Owners17.2%
Ins Owner Change-0.18%
Market Cap394.74M
Revenue(TTM)79.18M
Net Income(TTM)-64.72M
Analysts80
Price Target23.46 (19.69%)
Short Float %6.9%
Short Ratio2.94
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0.61% |
Yearly Dividend0
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)180.86%
Min EPS beat(2)40.59%
Max EPS beat(2)321.12%
EPS beat(4)3
Avg EPS beat(4)67.94%
Min EPS beat(4)-90.66%
Max EPS beat(4)321.12%
EPS beat(8)4
Avg EPS beat(8)33%
EPS beat(12)5
Avg EPS beat(12)12.67%
EPS beat(16)8
Avg EPS beat(16)15.11%
Revenue beat(2)2
Avg Revenue beat(2)0.99%
Min Revenue beat(2)0.63%
Max Revenue beat(2)1.36%
Revenue beat(4)3
Avg Revenue beat(4)0.73%
Min Revenue beat(4)-0.37%
Max Revenue beat(4)1.36%
Revenue beat(8)6
Avg Revenue beat(8)0.86%
Revenue beat(12)6
Avg Revenue beat(12)-0.85%
Revenue beat(16)10
Avg Revenue beat(16)0.61%
PT rev (1m)0%
PT rev (3m)-9.21%
EPS NQ rev (1m)57.58%
EPS NQ rev (3m)126.09%
EPS NY rev (1m)88.82%
EPS NY rev (3m)82.04%
Revenue NQ rev (1m)-0.78%
Revenue NQ rev (3m)-0.24%
Revenue NY rev (1m)0.39%
Revenue NY rev (3m)-0.09%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 28 | ||
| Fwd PE | 20.14 | ||
| P/S | 4.99 | ||
| P/FCF | 27.41 | ||
| P/OCF | 21.78 | ||
| P/B | 3.16 | ||
| P/tB | 7.61 | ||
| EV/EBITDA | 24.55 |
EPS(TTM)0.7
EY3.57%
EPS(NY)0.97
Fwd EY4.96%
FCF(TTM)0.72
FCFY3.65%
OCF(TTM)0.9
OCFY4.59%
SpS3.93
BVpS6.2
TBVpS2.58
PEG (NY)0.87
PEG (5Y)26.22
Graham Number9.88
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -49.05% | ||
| ROE | -51.86% | ||
| ROCE | 5.18% | ||
| ROIC | 4.16% | ||
| ROICexc | 5.61% | ||
| ROICexgc | 26.12% | ||
| OM | 8.2% | ||
| PM (TTM) | N/A | ||
| GM | 58.38% | ||
| FCFM | 18.19% |
ROA(3y)-12.88%
ROA(5y)-5.32%
ROE(3y)-13.51%
ROE(5y)-5.53%
ROIC(3y)3.61%
ROIC(5y)4.56%
ROICexc(3y)6.84%
ROICexc(5y)12.7%
ROICexgc(3y)60.47%
ROICexgc(5y)79.01%
ROCE(3y)4.51%
ROCE(5y)5.69%
ROICexgc growth 3Y-33.77%
ROICexgc growth 5Y-24.05%
ROICexc growth 3Y-37.37%
ROICexc growth 5Y-22.33%
OM growth 3Y-33.32%
OM growth 5Y-21.72%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-9.94%
GM growth 5Y-4.73%
F-Score5
Asset Turnover0.6
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | 0 | ||
| Debt/EBITDA | 0 | ||
| Cap/Depr | 45.34% | ||
| Cap/Sales | 4.7% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 123.28% | ||
| Profit Quality | N/A | ||
| Current Ratio | 7.67 | ||
| Quick Ratio | 7.67 | ||
| Altman-Z | 34 |
F-Score5
WACC9.68%
ROIC/WACC0.43
Cap/Depr(3y)77.49%
Cap/Depr(5y)94.25%
Cap/Sales(3y)6%
Cap/Sales(5y)7.05%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)75%
EPS 3Y-1.12%
EPS 5Y1.07%
EPS Q2Q%1200%
EPS Next Y32.34%
EPS Next 2Y29.52%
EPS Next 3Y2.03%
EPS Next 5Y22.12%
Revenue 1Y (TTM)13.09%
Revenue growth 3Y13.67%
Revenue growth 5Y13.74%
Sales Q2Q%-2.66%
Revenue Next Year1.9%
Revenue Next 2Y4.44%
Revenue Next 3Y5.79%
Revenue Next 5Y10.39%
EBIT growth 1Y5.89%
EBIT growth 3Y-24.21%
EBIT growth 5Y-10.96%
EBIT Next Year143.92%
EBIT Next 3Y43.31%
EBIT Next 5Y28.01%
FCF growth 1Y59.7%
FCF growth 3Y1.12%
FCF growth 5Y11.57%
OCF growth 1Y36.08%
OCF growth 3Y0.42%
OCF growth 5Y10.69%
SIMULATIONS PLUS INC / SLP FAQ
What is the ChartMill fundamental rating of SIMULATIONS PLUS INC (SLP) stock?
ChartMill assigns a fundamental rating of 6 / 10 to SLP.
Can you provide the valuation status for SIMULATIONS PLUS INC?
ChartMill assigns a valuation rating of 4 / 10 to SIMULATIONS PLUS INC (SLP). This can be considered as Fairly Valued.
How profitable is SIMULATIONS PLUS INC (SLP) stock?
SIMULATIONS PLUS INC (SLP) has a profitability rating of 4 / 10.
What is the financial health of SIMULATIONS PLUS INC (SLP) stock?
The financial health rating of SIMULATIONS PLUS INC (SLP) is 8 / 10.
Can you provide the expected EPS growth for SLP stock?
The Earnings per Share (EPS) of SIMULATIONS PLUS INC (SLP) is expected to grow by 32.34% in the next year.